fda warning bpc-157 2023 2024 The hype around a new class of injectable drugs is in overdrive, but they have yet to be properly tested. Read the full story from Kishor Napier-Raman at the link in bio., Photo: Oscar Colman FDA to weigh easing limits
Description
How does a substance or method get included on the WADA Prohibited List
Rotate sites to prevent lipodystrophy
If you are transitioning from semaglutide to retatrutide, allow a washout period of at least 5-7 half-lives of the outgoing compound before beginning the retatrutide escalation
You stay full longer
